• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过2017 - 2020年美国国家健康与营养检查调查(NHANES)的受控衰减参数评估非酒精性脂肪性肝病的自动化机器学习模型。

Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020.

作者信息

Liu Lihe, Lin Jiaxi, Liu Lu, Gao Jingwen, Xu Guoting, Yin Minyue, Liu Xiaolin, Wu Airong, Zhu Jinzhou

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

出版信息

Digit Health. 2024 Aug 7;10:20552076241272535. doi: 10.1177/20552076241272535. eCollection 2024 Jan-Dec.

DOI:10.1177/20552076241272535
PMID:39119551
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11307367/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is recognized as one of the most common chronic liver diseases worldwide. This study aims to assess the efficacy of automated machine learning (AutoML) in the identification of NAFLD using a population-based cross-sectional database.

METHODS

All data, including laboratory examinations, anthropometric measurements, and demographic variables, were obtained from the National Health and Nutrition Examination Survey (NHANES). NAFLD was defined by controlled attenuation parameter (CAP) in liver transient ultrasound elastography. The least absolute shrinkage and selection operator (LASSO) regression analysis was employed for feature selection. Six algorithms were utilized on the H2O-automated machine learning platform: Gradient Boosting Machine (GBM), Distributed Random Forest (DRF), Extremely Randomized Trees (XRT), Generalized Linear Model (GLM), eXtreme Gradient Boosting (XGBoost), and Deep Learning (DL). These algorithms were selected for their diverse strengths, including their ability to handle complex, non-linear relationships, provide high predictive accuracy, and ensure interpretability. The models were evaluated by area under receiver operating characteristic curves (AUC) and interpreted by the calibration curve, the decision curve analysis, variable importance plot, SHapley Additive exPlanation plot, partial dependence plots, and local interpretable model agnostic explanation plot.

RESULTS

A total of 4177 participants (non-NAFLD 3167 vs NAFLD 1010) were included to develop and validate the AutoML models. The model developed by XGBoost performed better than other models in AutoML, achieving an AUC of 0.859, an accuracy of 0.795, a sensitivity of 0.773, and a specificity of 0.802 on the validation set.

CONCLUSIONS

We developed an XGBoost model to better evaluate the presence of NAFLD. Based on the XGBoost model, we created an R Shiny web-based application named Shiny NAFLD (http://39.101.122.171:3838/App2/). This application demonstrates the potential of AutoML in clinical research and practice, offering a promising tool for the real-world identification of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)被认为是全球最常见的慢性肝病之一。本研究旨在使用基于人群的横断面数据库评估自动机器学习(AutoML)在识别NAFLD中的有效性。

方法

所有数据,包括实验室检查、人体测量和人口统计学变量,均来自国家健康和营养检查调查(NHANES)。NAFLD通过肝脏瞬时超声弹性成像中的受控衰减参数(CAP)来定义。采用最小绝对收缩和选择算子(LASSO)回归分析进行特征选择。在H2O自动机器学习平台上使用了六种算法:梯度提升机(GBM)、分布式随机森林(DRF)、极端随机树(XRT)、广义线性模型(GLM)、极端梯度提升(XGBoost)和深度学习(DL)。选择这些算法是因为它们具有多种优势,包括处理复杂非线性关系的能力、提供高预测准确性以及确保可解释性。通过受试者工作特征曲线下面积(AUC)评估模型,并通过校准曲线、决策曲线分析、变量重要性图、SHapley加性解释图、部分依赖图和局部可解释模型无关解释图进行解释。

结果

共纳入4177名参与者(非NAFLD 3167例与NAFLD 1010例)来开发和验证AutoML模型。XGBoost开发的模型在AutoML中表现优于其他模型,在验证集上的AUC为0.859,准确率为0.795,灵敏度为0.773,特异性为0.802。

结论

我们开发了一个XGBoost模型以更好地评估NAFLD的存在。基于XGBoost模型,我们创建了一个名为Shiny NAFLD(http://39.101.122.171:3838/App2/)的基于R Shiny的网络应用程序。该应用程序展示了AutoML在临床研究和实践中的潜力,为现实世界中NAFLD的识别提供了一个有前景的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/a681dddfd031/10.1177_20552076241272535-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/5bd7cbfae6ff/10.1177_20552076241272535-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/650bb266ed34/10.1177_20552076241272535-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/6365ecdf5617/10.1177_20552076241272535-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/d6fcac751fa1/10.1177_20552076241272535-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/f8cc6140408c/10.1177_20552076241272535-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/417044963e6f/10.1177_20552076241272535-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/c481004aa41a/10.1177_20552076241272535-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/a681dddfd031/10.1177_20552076241272535-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/5bd7cbfae6ff/10.1177_20552076241272535-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/650bb266ed34/10.1177_20552076241272535-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/6365ecdf5617/10.1177_20552076241272535-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/d6fcac751fa1/10.1177_20552076241272535-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/f8cc6140408c/10.1177_20552076241272535-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/417044963e6f/10.1177_20552076241272535-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/c481004aa41a/10.1177_20552076241272535-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca4/11307367/a681dddfd031/10.1177_20552076241272535-fig8.jpg

相似文献

1
Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020.通过2017 - 2020年美国国家健康与营养检查调查(NHANES)的受控衰减参数评估非酒精性脂肪性肝病的自动化机器学习模型。
Digit Health. 2024 Aug 7;10:20552076241272535. doi: 10.1177/20552076241272535. eCollection 2024 Jan-Dec.
2
Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis.自动机器学习在预测非胆汁淤积性肝硬化患者30天死亡率中的应用
J Pers Med. 2022 Nov 19;12(11):1930. doi: 10.3390/jpm12111930.
3
Automated Machine Learning for the Early Prediction of the Severity of Acute Pancreatitis in Hospitals.医院中急性胰腺炎严重程度早期预测的自动化机器学习。
Front Cell Infect Microbiol. 2022 Jun 10;12:886935. doi: 10.3389/fcimb.2022.886935. eCollection 2022.
4
Development and validation of machine learning models for nonalcoholic fatty liver disease.机器学习模型在非酒精性脂肪性肝病中的开发和验证。
Hepatobiliary Pancreat Dis Int. 2023 Dec;22(6):615-621. doi: 10.1016/j.hbpd.2023.03.009. Epub 2023 Mar 25.
5
Automated machine learning for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based analysis.基于 SEER 数据库的自动化机器学习预测胃肠道间质瘤患者肝转移的研究
Sci Rep. 2024 May 30;14(1):12415. doi: 10.1038/s41598-024-62311-9.
6
Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.利用机器学习模型预测非酒精性脂肪性肝病的 5 年风险:前瞻性队列研究。
J Med Internet Res. 2023 Sep 12;25:e46891. doi: 10.2196/46891.
7
Automated machine learning to predict the difficulty for endoscopic resection of gastric gastrointestinal stromal tumor.利用自动机器学习预测胃胃肠道间质瘤内镜切除的难度
Front Oncol. 2023 May 10;13:1190987. doi: 10.3389/fonc.2023.1190987. eCollection 2023.
8
Automated machine learning for early prediction of acute kidney injury in acute pancreatitis.急性胰腺炎中急性肾损伤的早期预测的自动化机器学习。
BMC Med Inform Decis Mak. 2024 Jan 11;24(1):16. doi: 10.1186/s12911-024-02414-5.
9
Prediction Model of Osteonecrosis of the Femoral Head After Femoral Neck Fracture: Machine Learning-Based Development and Validation Study.股骨颈骨折后股骨头坏死的预测模型:基于机器学习的开发与验证研究
JMIR Med Inform. 2021 Nov 19;9(11):e30079. doi: 10.2196/30079.
10
Development of Cost-Effective Fatty Liver Disease Prediction Models in a Chinese Population: Statistical and Machine Learning Approaches.中国人群中具有成本效益的脂肪肝疾病预测模型的开发:统计和机器学习方法
JMIR Form Res. 2024 Feb 16;8:e53654. doi: 10.2196/53654.

引用本文的文献

1
Applications and challenges of biomarker-based predictive models in proactive health management.基于生物标志物的预测模型在主动健康管理中的应用与挑战
Front Public Health. 2025 Aug 18;13:1633487. doi: 10.3389/fpubh.2025.1633487. eCollection 2025.
2
Machine learning-based disease risk stratification and prediction of metabolic dysfunction-associated fatty liver disease using vibration-controlled transient elastography: Result from NHANES 2021-2023.基于机器学习的代谢功能障碍相关脂肪性肝病的疾病风险分层及利用振动控制瞬时弹性成像进行预测:美国国家健康与营养检查调查2021 - 2023年的结果
BMC Gastroenterol. 2025 Apr 14;25(1):255. doi: 10.1186/s12876-025-03850-x.
3

本文引用的文献

1
Automated machine learning for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based analysis.基于 SEER 数据库的自动化机器学习预测胃肠道间质瘤患者肝转移的研究
Sci Rep. 2024 May 30;14(1):12415. doi: 10.1038/s41598-024-62311-9.
2
An Artificial Neural Network Model Combined with Dietary Retinol Intake from Different Sources to Predict the Risk of Nonalcoholic Fatty Liver Disease.一种结合不同来源饮食视黄醇摄入量的人工神经网络模型预测非酒精性脂肪肝疾病风险。
Biomed Environ Sci. 2023 Dec 20;36(12):1123-1135. doi: 10.3967/bes2023.120.
3
Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study.
Comparison of Deep Learning and Traditional Machine Learning Models for Predicting Mild Cognitive Impairment Using Plasma Proteomic Biomarkers.
使用血浆蛋白质组学生物标志物预测轻度认知障碍的深度学习与传统机器学习模型比较
Int J Mol Sci. 2025 Mar 8;26(6):2428. doi: 10.3390/ijms26062428.
基于多模态数据的人工智能诊断临床显著前列腺癌:一项多中心研究。
BMC Med. 2023 Jul 24;21(1):270. doi: 10.1186/s12916-023-02964-x.
4
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的无创诊断和监测。
Lancet Gastroenterol Hepatol. 2023 Jul;8(7):660-670. doi: 10.1016/S2468-1253(23)00066-3. Epub 2023 Apr 13.
5
Development and validation of machine learning models for nonalcoholic fatty liver disease.机器学习模型在非酒精性脂肪性肝病中的开发和验证。
Hepatobiliary Pancreat Dis Int. 2023 Dec;22(6):615-621. doi: 10.1016/j.hbpd.2023.03.009. Epub 2023 Mar 25.
6
The nonalcoholic fatty liver risk in prediction of unfavorable outcome after stroke: A nationwide registry analysis.非酒精性脂肪肝风险对卒中后不良结局的预测作用:一项全国性登记分析
Comput Biol Med. 2023 May;157:106692. doi: 10.1016/j.compbiomed.2023.106692. Epub 2023 Feb 28.
7
Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.基于生物信息学分析和机器学习策略识别非酒精性脂肪性肝病的潜在特征基因。
Comput Biol Med. 2023 May;157:106724. doi: 10.1016/j.compbiomed.2023.106724. Epub 2023 Mar 5.
8
Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults.机器学习分类器在一般成年人中非酒精性脂肪性肝病筛查中的应用。
Sci Rep. 2023 Mar 3;13(1):3638. doi: 10.1038/s41598-023-30750-5.
9
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review.种族和民族在非酒精性脂肪性肝病(NAFLD)中的作用:一项叙述性综述。
Nutrients. 2022 Oct 28;14(21):4556. doi: 10.3390/nu14214556.
10
Automated Multimodal Machine Learning for Esophageal Variceal Bleeding Prediction Based on Endoscopy and Structured Data.基于内镜和结构化数据的食管静脉曲张出血预测的自动化多模态机器学习。
J Digit Imaging. 2023 Feb;36(1):326-338. doi: 10.1007/s10278-022-00724-6. Epub 2022 Oct 24.